Global 3D Printing Pharmaceuticals 麻豆原创 Research Report 2023

Publication ID:

PB502237826

Publication Date:

February 14, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
The global 3D Printing Pharmaceuticals market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for 3D Printing Pharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for 3D Printing Pharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of 3D Printing Pharmaceuticals include Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA and TNO, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 3D Printing Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printing Pharmaceuticals.
The 3D Printing Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global 3D Printing Pharmaceuticals market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Printing Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Triastek,Inc.
Aprecia
AstraZeneca
FabRx
Multiply Labs
DiHeSys
Merck
Merck KGaA
TNO
Therics
Segment by Type
FDM
SLS
PB
SLA
SSE
DPE
DOD
MDD
MED
Segment by Application
Personalized Pharmacy
Nutrients
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 3D Printing Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 3D Printing Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 3D Printing Pharmaceuticals 麻豆原创 Overview
1.1 Product Overview and Scope of 3D Printing Pharmaceuticals
1.2 3D Printing Pharmaceuticals Segment by Type
1.2.1 Global 3D Printing Pharmaceuticals 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 FDM
1.2.3 SLS
1.2.4 PB
1.2.5 SLA
1.2.6 SSE
1.2.7 DPE
1.2.8 DOD
1.2.9 MDD
1.2.10 MED
1.3 3D Printing Pharmaceuticals Segment by Application
1.3.1 Global 3D Printing Pharmaceuticals 麻豆原创 Value by Application: (2023-2029)
1.3.2 Personalized Pharmacy
1.3.3 Nutrients
1.4 Global 3D Printing Pharmaceuticals 麻豆原创 Size Estimates and Forecasts
1.4.1 Global 3D Printing Pharmaceuticals Revenue 2018-2029
1.4.2 Global 3D Printing Pharmaceuticals Sales 2018-2029
1.4.3 Global 3D Printing Pharmaceuticals 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 3D Printing Pharmaceuticals 麻豆原创 Competition by Manufacturers
2.1 Global 3D Printing Pharmaceuticals Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global 3D Printing Pharmaceuticals Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global 3D Printing Pharmaceuticals Average Price by Manufacturers (2018-2023)
2.4 Global 3D Printing Pharmaceuticals Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of 3D Printing Pharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 3D Printing Pharmaceuticals, Product Type & Application
2.7 3D Printing Pharmaceuticals 麻豆原创 Competitive Situation and Trends
2.7.1 3D Printing Pharmaceuticals 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 3D Printing Pharmaceuticals Players 麻豆原创 Share by Revenue
2.7.3 Global 3D Printing Pharmaceuticals 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 3D Printing Pharmaceuticals Retrospective 麻豆原创 Scenario by Region
3.1 Global 3D Printing Pharmaceuticals 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global 3D Printing Pharmaceuticals Global 3D Printing Pharmaceuticals Sales by Region: 2018-2029
3.2.1 Global 3D Printing Pharmaceuticals Sales by Region: 2018-2023
3.2.2 Global 3D Printing Pharmaceuticals Sales by Region: 2024-2029
3.3 Global 3D Printing Pharmaceuticals Global 3D Printing Pharmaceuticals Revenue by Region: 2018-2029
3.3.1 Global 3D Printing Pharmaceuticals Revenue by Region: 2018-2023
3.3.2 Global 3D Printing Pharmaceuticals Revenue by Region: 2024-2029
3.4 North America 3D Printing Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.4.1 North America 3D Printing Pharmaceuticals 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America 3D Printing Pharmaceuticals Sales by Country (2018-2029)
3.4.3 North America 3D Printing Pharmaceuticals Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe 3D Printing Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.5.1 Europe 3D Printing Pharmaceuticals 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe 3D Printing Pharmaceuticals Sales by Country (2018-2029)
3.5.3 Europe 3D Printing Pharmaceuticals Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 3D Printing Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific 3D Printing Pharmaceuticals 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific 3D Printing Pharmaceuticals Sales by Country (2018-2029)
3.6.3 Asia Pacific 3D Printing Pharmaceuticals Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 3D Printing Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.7.1 Latin America 3D Printing Pharmaceuticals 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America 3D Printing Pharmaceuticals Sales by Country (2018-2029)
3.7.3 Latin America 3D Printing Pharmaceuticals Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa 3D Printing Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa 3D Printing Pharmaceuticals 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2018-2029)
3.8.3 Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 3D Printing Pharmaceuticals Sales by Type (2018-2029)
4.1.1 Global 3D Printing Pharmaceuticals Sales by Type (2018-2023)
4.1.2 Global 3D Printing Pharmaceuticals Sales by Type (2024-2029)
4.1.3 Global 3D Printing Pharmaceuticals Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global 3D Printing Pharmaceuticals Revenue by Type (2018-2029)
4.2.1 Global 3D Printing Pharmaceuticals Revenue by Type (2018-2023)
4.2.2 Global 3D Printing Pharmaceuticals Revenue by Type (2024-2029)
4.2.3 Global 3D Printing Pharmaceuticals Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global 3D Printing Pharmaceuticals Price by Type (2018-2029)
5 Segment by Application
5.1 Global 3D Printing Pharmaceuticals Sales by Application (2018-2029)
5.1.1 Global 3D Printing Pharmaceuticals Sales by Application (2018-2023)
5.1.2 Global 3D Printing Pharmaceuticals Sales by Application (2024-2029)
5.1.3 Global 3D Printing Pharmaceuticals Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global 3D Printing Pharmaceuticals Revenue by Application (2018-2029)
5.2.1 Global 3D Printing Pharmaceuticals Revenue by Application (2018-2023)
5.2.2 Global 3D Printing Pharmaceuticals Revenue by Application (2024-2029)
5.2.3 Global 3D Printing Pharmaceuticals Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global 3D Printing Pharmaceuticals Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Triastek,Inc.
6.1.1 Triastek,Inc. Corporation Information
6.1.2 Triastek,Inc. Description and Business Overview
6.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Triastek,Inc. 3D Printing Pharmaceuticals Product Portfolio
6.1.5 Triastek,Inc. Recent Developments/Updates
6.2 Aprecia
6.2.1 Aprecia Corporation Information
6.2.2 Aprecia Description and Business Overview
6.2.3 Aprecia 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Aprecia 3D Printing Pharmaceuticals Product Portfolio
6.2.5 Aprecia Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AstraZeneca 3D Printing Pharmaceuticals Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 FabRx
6.4.1 FabRx Corporation Information
6.4.2 FabRx Description and Business Overview
6.4.3 FabRx 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.4.4 FabRx 3D Printing Pharmaceuticals Product Portfolio
6.4.5 FabRx Recent Developments/Updates
6.5 Multiply Labs
6.5.1 Multiply Labs Corporation Information
6.5.2 Multiply Labs Description and Business Overview
6.5.3 Multiply Labs 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Multiply Labs 3D Printing Pharmaceuticals Product Portfolio
6.5.5 Multiply Labs Recent Developments/Updates
6.6 DiHeSys
6.6.1 DiHeSys Corporation Information
6.6.2 DiHeSys Description and Business Overview
6.6.3 DiHeSys 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.6.4 DiHeSys 3D Printing Pharmaceuticals Product Portfolio
6.6.5 DiHeSys Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck 3D Printing Pharmaceuticals Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Merck KGaA
6.8.1 Merck KGaA Corporation Information
6.8.2 Merck KGaA Description and Business Overview
6.8.3 Merck KGaA 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Merck KGaA 3D Printing Pharmaceuticals Product Portfolio
6.8.5 Merck KGaA Recent Developments/Updates
6.9 TNO
6.9.1 TNO Corporation Information
6.9.2 TNO Description and Business Overview
6.9.3 TNO 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.9.4 TNO 3D Printing Pharmaceuticals Product Portfolio
6.9.5 TNO Recent Developments/Updates
6.10 Therics
6.10.1 Therics Corporation Information
6.10.2 Therics Description and Business Overview
6.10.3 Therics 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Therics 3D Printing Pharmaceuticals Product Portfolio
6.10.5 Therics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 3D Printing Pharmaceuticals Industry Chain Analysis
7.2 3D Printing Pharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 3D Printing Pharmaceuticals Production Mode & Process
7.4 3D Printing Pharmaceuticals Sales and 麻豆原创ing
7.4.1 3D Printing Pharmaceuticals Sales Channels
7.4.2 3D Printing Pharmaceuticals Distributors
7.5 3D Printing Pharmaceuticals Customers
8 3D Printing Pharmaceuticals 麻豆原创 Dynamics
8.1 3D Printing Pharmaceuticals Industry Trends
8.2 3D Printing Pharmaceuticals 麻豆原创 Drivers
8.3 3D Printing Pharmaceuticals 麻豆原创 Challenges
8.4 3D Printing Pharmaceuticals 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Triastek,Inc.
Aprecia
AstraZeneca
FabRx
Multiply Labs
DiHeSys
Merck
Merck KGaA
TNO
Therics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.